Pfizer beats first-quarter earnings estimates in race to develop coronavirus vaccine

reported Tuesday first-quarter earnings that beat Wall Street estimates and reaffirmed its full-year revenue guidance as the drugmaker works to develop a vaccine to prevent the coronavirus.

The drugmaker reported adjusted earnings of 80 cents per share, 7 cents higher than Wall Street analysts polled by Refinitiv expected. The company reported revenue of $12 billion, higher than the $11.8 billion expected.Pfizer estimates it can potentially produce millions of coronavirus vaccine doses by the end of this year.

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Kuehne & Nagel quarterly core earnings fall on coronavirus crisisSwiss freight-forwarding group Kuehne und Nagel International on Monday reported a 24% fall in first-quarter core earnings, as industrial production and trade volumes declined due to the novel coronavirus pandemic.
La source: Reuters - 🏆 2. / 97 Lire la suite »

Caterpillar is about to report earnings, and Oppenheimer sees stock stabilizingCaterpillar is set to report earnings, one of the largest industrials stocks to give insight into how the coronavirus pandemic has hit the sector. TradingNation TradingNation Upside? For Cat? In 2020? Yeah right.
La source: CNBC - 🏆 12. / 72 Lire la suite »